Frank Harvey, CEO at Surescripts Community pharmacists trusted to deliver care: In 2023, pharmacists will play an integral role as part of the team managing patient care for diseases like diabetes, hypertension, or multiple comorbidities. And to support this work, I predict that we will see more activity between payers, pharmacists, the government and technology organizations to ensure that pharmacists are able to perform these important activities and be reimbursed for their work. Greg
Read More
5 Executive Healthcare Cybersecurity Predictions to Watch in 2023
Irfan Shakeel, VP of Training and Certification Services, OPSWAT Cyberattacks on the healthcare industry will continue to increase: The healthcare industry is most vulnerable to cyberattacks, which makes it a lucrative target for cybercriminals; attacks on the healthcare industry have grown significantly in 2022, and attacks will even go further in 2023. According to IBM, healthcare breaches cost the most at $9.23 million per incident. And, most importantly, cyberattacks not only affect human
Read More
7 Life Sciences Executive Predictions to Watch in 2023
Tracy Curley, CFO and interim CEO at iSpecimen Focusing on the macroeconomic environment, which remains impacted by the lingering COVID-19 pandemic, there continues to be uncertainty about the strength of the global, Asia Pacific, UK and US economies. High-interest rates and a potential recession remain a concern for all market participants. At ISPC, we are closely monitoring the pace of specimen transactions. We believe that this industry can be resilient through a continued economic
Read More
Exec Hires: Former WebMD Exec Joins ODAIA as New Chief Commercial Officer
What You Should Know: - ODAIA, the company empowering pharma’s next generation of engagement with healthcare professionals through predictive analytics announces the appointment of Dr. Eric Trépanier (Pharm.D, CFA) as its new Chief Commercial Officer. - As Chief Commerical Officer, Trépanier will drive sales of ODAIA’s MAPTUAL Sphere and MAPTUAL Field products, which aim to expand and deepen relationships between physicians and the commercial teams and sales reps at pharma
Read More
Real-World Data Startup Crescendo Health Launches with $3.2M
What You Should Know: - Crescendo Health, a real-world data startup that's drastically reshaping how clinical researchers get access to hard-to-reach patient data to support their clinical research today officially announced its launch with $3.4M in seed funding from Define Ventures as well as the founders and CEOs of many other well-known organizations. - Founded by the co-founder of Datavant (merged with Ciox in a $7 billion deal), and a top product-management leader from Grand
Read More
The Patient Journey Tech Stack: 10 Pharma Predictions for 2023
The complexity of demands on Market Access teams has increased in recent years, between introducing innovative therapies targeting smaller populations and higher bars from Payers and PBMs. Now, drug manufacturers are bucking up. According to the IQVIA Institute, the prescription abandonment rate has reached 27 percent, or $76 billion annually, in specialty drugs alone. This squandered revenue has led manufacturers to increase their focus on the complex, nuanced patient journey. As a
Read More
When Innovation Isn’t Enough: Pharma’s Next Frontier
I met Mark Cuban once. Our conversation didn’t last very long. It was at a medical conference a few years ago. Cuban felt like a great guy to approach with an idea for a healthcare startup. We were both investors in an automation software startup called Zoba, and I of course knew him from his role on the popular entrepreneurial reality TV series Shark Tank. A few seconds into our conversation, Cuban paused. “Healthcare is hard,” he sighed. That was his way of politely telling me: for that
Read More
Analysis: RSNA 2022: Predictions vs Reality
Much has already been written about attendance at RSNA, but from a first-hand perspective, RSNA 2022 could be regarded as a step back toward “normal”. Amongst mostly bustling halls, vendors reported very positive feedback on the volume and quality of customer meetings, with one prominent global imaging vendor citing “We’re signing deals here at the show again – things are looking up”. Against this positive backdrop, however, the stark challenges facing radiology in a post-COVID world were
Read More
AI/ML Used for Clinical Trial-Site Identification Simultaneously Improves Enrollment Rates and Diversity
Ethnic and racial minorities are commonly underrepresented in clinical trials. This problem is so severe that in April, the U.S. Food and Drug Administration (FDA) expanded upon existing guidance to further emphasize recommendations to sponsors developing treatments to increase enrollment from underrepresented populations in the U.S., including African-American, Hispanic, Asian and other persons of color, in clinical trials. In the updated guidance, the FDA provided details on what sponsors
Read More
Protecting AI’s Boundless Potential in Healthcare
Artificial intelligence can do amazing things for patients, providers and the healthcare business — but only if the right cyber safeguards are in place. For more than a decade, a cybercrime syndicate known as Evil Corp has tormented organizations around the world with malware and ransomware attacks. And now, it seems, the group has designs on healthcare companies. “Evil Corp should be considered a significant threat to the U.S. health sector,” the Health Sector Cybersecurity
Read More
